How ideology shapes the evidence and the policy: What do we know about cannabis use and what should we do?

Addiction

Volumn 105, Issue 8, 2010, Pages 1326-1330

  MacLeod, John ^a   Hickman, Matthew ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Cannabis; evidence; public health; schizophrenia

Indexed keywords

ADULT; ARTICLE; CANNABIS ADDICTION; CANNABIS SMOKING; EPIDEMIOLOGY; EVIDENCE BASED MEDICINE; FEMALE; HUMAN; LEGAL ASPECT; MALE; MANAGEMENT; POLICY; PUBLIC HEALTH; RESEARCH; RISK FACTOR; SCHIZOPHRENIA; UNITED KINGDOM;

ADULT; BIAS (EPIDEMIOLOGY); EVIDENCE-BASED MEDICINE; FEMALE; GREAT BRITAIN; HUMANS; MALE; MARIJUANA ABUSE; MARIJUANA SMOKING; POLICY MAKING; PUBLIC HEALTH; PUBLIC POLICY; RESEARCH; RISK FACTORS; SCHIZOPHRENIA;

EID: 77954495784     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2009.02846.x     Document Type: Article

References (41)

1. Hickman M., Vickerman P., Macleod J., Kirkbride J., Jones P. B. Cannabis and schizophrenia: model projections of the impact of the rise in cannabis use on historical and future trends in schizophrenia in England and Wales. Addiction 2007 102 : 597 606.
2. Aust R., Sharp C., Goulden C. Prevalence of Drug Use: Key Findings from the 2001/2002 British Crime Survey. Findings 182.
3. Advisory Council on the Misuse of Drugs. Cannabis: Classification and Public Health.
4. van Os J., Bak M., Hanssen M., Bijl R. V., de Graaf R., Verdoux H. Cannabis use and psychosis: a longitudinal population-based study. Am J Epidemiol 2002 156 : 319 327.
5. Arseneault L., Cannon M., Poulton R., Murray R., Caspi A., Moffitt T. E. Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. BMJ 2002 325 : 1212 1213.
6. Fergusson D. M., Horwood L. J., Swain-Campbell N. R. Cannabis dependence and psychotic symptoms in young people. Psychol Med 2003 33 : 15 21.
7. Henquet C., Krabbendam L., Spauwen J., Kaplan C., Lieb R., Wittchen H. U. et al. Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people. BMJ 2005 330 : 11.
8. Andréasson S., Allebeck P., Engström A., Rydberg U. Cannabis and schizophrenia: a longitudinal study of Swedish conscripts. Lancet 1987 330 : 1483 1486.
9. Macleod J., Oakes R., Copello A., Crome I., Egger M., Hickman M. et al. The psychosocial consequences of use of cannabis and other illicit drugs: systematic review of longitudinal, general population studies. Lancet 2004 363 : 1579 1588.
10. Hall W. Is cannabis use psychotogenic? Lancet 2006 367 : 193 195.
11. Lawlor D. A., Davey S. G., Ebrahim S. Commentary. The hormone replacement-coronary heart disease conundrum: is this the death of observational epidemiology? Int J Epidemiol 2004 33 : 464 467.
12. Petitti D. Commentary. Hormone replacement therapy and coronary heart disease: four lessons. Int J Epidemiol 2004 33 : 461 463.
13. Moore T. H., Zammit S., Lingford-Hughes A., Barnes T. R., Jones P. B., Burke M. et al. Systematic review of cannabis use and risk of developing psychotic or affective mental health outcomes. Lancet 2007 370 : 319 328.
14. Arseneault L., Cannon M., Witton J., Murray R. M. Causal association between cannabis and psychosis: examination of the evidence. Br J Psychiatry 2004 184 : 110 117.
15. Iversen L. Long-term effects of exposure to cannabis. Curr Opin Pharmacol 2005 5 : 69 72.
16. Macleod J., Davey S. G., Hickman M. Does cannabis use cause schizophrenia? Lancet 2006 367 : 1055.
17. Murray R., Jones P., Susser E., van Os J., Cannon M. The Epidemiology of Schizophrenia.
18. Marshall B. J., Warren J. R. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984 1 : 1311 1315.
19. Hall W., Pacula R. Cannabis Use and Dependence: Public Health and Public Policy.
20. Hashibe M., Morgenstern H., Cui Y., Tashkin D. P., Zhang Z. F., Cozen W. et al. Marijuana use and the risk of lung and upper aerodigestive tract cancers: results of a population-based case-control study. Cancer Epidemiol Biomarkers Prev 2006 15 : 1829 1834.
21. Tashkin D. P. Does smoking marijuana increase the risk of chronic obstructive pulmonary disease? Can Med Assoc J 2009 180 : 797 798.
22. Robertson J. R., Miller P., Anderson R. Cannabis use in the community. Br J Gen Pract 1996 46 : 671 674.
23. Patton G. C., Coffey C., Carlin J. B., Sawyer S. M., Lynskey M. Reverse gateways? Frequent cannabis use as a predictor of tobacco initiation and nicotine dependence. Addiction 2005 100 : 1518 1525.
24. Office of National Statistics (ONS). Psychiatric Morbidity Among Adults Living in Private Households, 2000. http://www.statistics.gov.uk/downloads/ theme-health/psychmorb.pdf (accessed 26 November 2009).
25. Nordstrom B. R., Levin F. R. Treatment of cannabis use disorders: a review of the literature. Am J Addict 2007 16 : 331 342.
26. Hall W. D. The contribution of research to the development of a national cannabis policy in Australia. Addiction 2008 103 : 712 720.
27. Wynder E. L., Higgins I. T., Harris R. E. The wish bias. J Clin Epidemiol 1990 43 : 619 621.
28. 1st European Conference on Schizophrenia Research - Perspectives from European Networks, September 2007, Germany. Eur Arch Psychiatry Clin Neurosci 2007 257 : 1 40.
29. Linszen D. H., Dingemans P. M., Lenior M. E. Cannabis abuse and the course of recent-onset schizophrenic disorders. Arch Gen Psychiatry 1994 51 : 273 279.
30. Caspi A., Moffitt T. E., Cannon M., McClay J., Murray R., Harrington H. et al. Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene-environment interaction. Biol Psychiatry 2005 57 : 1117 1127.
31. Caspi A., Sugden K., Moffitt T. E., Taylor A., Craig I. W., Harrington H. et al. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 2003 301 : 386 389.
32. Munafo M. R., Bowes L., Clark T. G., Flint J. Lack of association of the COMT (Val158/108 Met) gene and schizophrenia: a meta-analysis of case-control studies. Mol Psychiatry 2005 10 : 765 770.
33. Munafo M. R., Durrant C., Lewis G., Flint J. Gene-environment interactions at the serotonin transporter locus. Biol Psychiatry 2009 65 : 211 219.
34. Zammit S., Spurlock G., Williams H., Norton N., Williams N., O'Donovan M. C. et al. Genotype effects of CHRNA7, CNR1 and COMT in schizophrenia: interactions with tobacco and cannabis use. Br J Psychiatry 2007 191 : 402 407.
35. Risch N., Herrell R., Lehner T., Liang K. Y., Eaves L., Hoh J. et al. Interaction between the serotonin transporter gene (5-HTTLPR), stressful life events, and risk of depression: a meta-analysis. JAMA 2009 301 : 2462 2471.
36. Zammit S., Owen M. J. Stressful life events, 5-HTT genotype and risk of depression. Br J Psychiatry 2006 188 : 199 201.
37. Degenhardt L., Hall W., Lynskey M. Testing hypotheses about the relationship between cannabis use and psychosis. Drug Alcohol Depend 2003 71 : 37 48.
38. Hickman M., Vickerman P., Macleod J., Lewis G., Zammit S., Kirkbride J. et al. If cannabis caused schizophrenia - how many cannabis users may need to be prevented in order to prevent one case of schizophrenia? England and Wales calculations. Addiction 2009 104 : 1856 1861.
39. Amos A., Wiltshire S., Bostock Y., Haw S., McNeill A. You can't go without a fag. you need it for your hash - a qualitative exploration of smoking, cannabis and young people. Addiction 2004 99 : 77 81.
40. Fergusson D. M., Swain-Campbell N. R., Horwood L. J. Arrests and convictions for cannabis related offences in a New Zealand birth cohort. Drug Alcohol Depend 2003 70 : 53 63.
41. Reinarman C., Cohen P. D., Kaal H. L. The limited relevance of drug policy: cannabis in Amsterdam and in San Francisco. Am J Public Health 2004 94 : 836 842.